Softwr

Healthcare · head to head

Kareo vs Lunit

Kareo logo

Kareo

Healthcare

Cloud-based EHR and billing for small practices

From
$99/month
Rated
-
Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-

The short version

  • Each has a real cost: Kareo kareo is now part of Tebra and sold under the Tebra brand rather than as a standalone product; Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • They diverge on capability: Kareo covers Electronic Health Records, Lunit covers Lunit INSIGHT MMG.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Kareo and Lunit actually diverge.

Attributes where Kareo and Lunit differ
AttributeKareoLunit
Starting price$99/monthOn request
Pricing modelsubscriptionquote
PlatformsWeb, MobileWeb
Founded2010Unknown

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Kareo

  • Electronic Health Records
  • Scheduling
  • Patient Portal
  • Medical Billing
  • Payment Processing
  • Labs
  • Pharmacies
  • Clearinghouses

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

What people use each for

The jobs each tool is most often brought in to do.

Kareo

  • Practice management, scheduling and billing for independent medical practicesnot Lunit
  • Electronic health records and e-prescribing for small clinicsnot Lunit
  • Insurance claim submission and patient payment collectionnot Lunit

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot Kareo
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot Kareo
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot Kareo
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot Kareo

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Kareo

  • Kareo is now part of Tebra and sold under the Tebra brand rather than as a standalone product
  • Tebra publishes no rate: pricing varies with provider count, features and implementation requirements and is quoted during a demo
  • Billing counts clinical providers such as MDs, DOs, NPs and PAs, so adding a prescriber raises the bill even though non clinical staff are free
  • Electronic prescribing of controlled substances setup costs about $75 per provider as a one time fee
  • PDMP integration costs $500 one time per facility plus about $50 per user per year

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

Pricing, plan by plan

Kareo

$99/month
  • Starter$99/month
    • EHR
    • Scheduling
    • Patient Portal
  • Professional$199/month
    • Everything in Starter
    • Billing
    • Reporting

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

Which should you pick?

Choose Kareo if

  • You need electronic health records.
  • You work on Web, Mobile.
  • You also want scheduling.

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.

Questions people ask

Is Kareo or Lunit better?
Neither clearly leads. Kareo starts at $99/month and Lunit at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Kareo or Lunit?
Kareo starts at $99/month and Lunit at On request.
Does Kareo or Lunit run on more platforms?
Kareo runs on Web, Mobile. Lunit runs on Web.
What is Kareo best used for?
Kareo is most often used for practice management, scheduling and billing for independent medical practices, electronic health records and e-prescribing for small clinics, insurance claim submission and patient payment collection. Of those, practice management, scheduling and billing for independent medical practices and electronic health records and e-prescribing for small clinics are not what Lunit is typically brought in for.
What can Kareo do that Lunit cannot?
Kareo covers Electronic Health Records, Scheduling, Patient Portal, Medical Billing. Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment.

Answered from the vendors’ own pages

Kareo: Does Kareo publish its pricing?

No. Kareo (now rebranded as Tebra) uses custom per-practice pricing that varies based on the number of providers, features needed, and implementation requirements. Pricing is determined during a demo with the sales team.

Source
Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

Kareo: Are there discounts for adding multiple modules?

Yes. Tebra states that many practices qualify for bundled pricing or volume incentives when adopting multiple modules like EHR, billing, and patient experience tools together.

Source
Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

Kareo: What are the additional costs for controlled substance prescribing?

For providers who prescribe controlled substances, EPCS setup costs approximately $75 per provider as a one-time fee, and PDMP integration costs $500 one-time per facility plus around $50 per user per year.

Source
Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

Kareo: Does Kareo offer a free trial?

Kareo's website does not mention a free trial option. Access to pricing and trial arrangements requires contacting the sales team to request a demo.

Source
Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

Share

Related pages

Other head to heads